Guy's Cancer Center at King's College London has initiated an important clinical trial investigating thermography-controlled wIRA superficial hyperthermia using the hydrosun®TWH1500 system. This prospective study examines the real-world implementation of thermotherapy in conjunction with standard palliative radiotherapy.
Study Population: The trial focuses on three key patient groups:
- Patients with superficial inoperable/incurable locally advanced or recurrent/metastatic head & neck squamous cell carcinoma not suitable for radical treatment
- Patients with superficial inoperable/incurable locally advanced or recurrent/metastatic cutaneous squamous cell carcinoma not suitable for radical treatment
- Cases requiring re-irradiation of locally recurrent breast cancer (LRBC)
Study Details: Principal Investigator: Anthony Kong, MD Clinical Reader and Honorary NHS Consultant in Clinical Oncology Trial Registration: NCT06659146.
For further protocol information: https://clinicaltrials.gov/study/NCT06659146
This investigation represents a significant step in evaluating the clinical application of wIRA superficial hyperthermia in palliative care settings. The results will contribute valuable data on the integration of hyperthermia with standard palliative radiotherapy protocols.
